Business Context and Reporting Period
Company: American Shared Hospital Services
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 2003
Business Overview: The Company provides Gamma Knife radiosurgery units to medical centers through its majority-owned subsidiary, GK Financing, LLC. As of March 31, 2003, the Company operated 15 Gamma Knife units across the United States. Revenue models include fee-per-use contracts and revenue-sharing ("retail") agreements.
Key Financial Metrics
| Metric | Q1 2003 | Q1 2002 |
|---|---|---|
| Revenues (Medical Services) | $3,669,000 | $3,245,000 |
| Operating Income | $727,000 | $588,000 |
| Net Income | $336,000 | $320,000 |
| Diluted EPS | $0.07 | $0.06 |
| Cash Flow from Operations | $1,914,000 | $648,000 |
| Cash and Equivalents (End of Period) | $11,341,000 | $11,041,000 |
| Total Debt (Current + Long-term) | $28,847,000 | N/A |
| Working Capital | $7,373,000 | N/A |
Material Changes vs. Prior Period
- Revenue Growth: Revenues increased by $424,000 (13.1%) driven by the addition of three new Gamma Knife units and a 3% revenue increase at existing centers. Total procedures rose to 490 from 410.
- Operating Expenses: Total costs of operations increased by $300,000. Maintenance and supplies rose $66,000 due to more units under contract. Depreciation increased $138,000 due to new assets. Selling and administrative costs increased $28,000, largely due to a $58,000 write-off of deferred costs for a Gamma Knife unit originally scheduled for Brazil but reallocated.
- Interest Expense: Decreased by $43,000 to $581,000. Lower rates on newer units and principal paydowns on mature loans offset interest on new financings.
- Tax Expense: Increased by $92,000 to $197,000. The effective tax rate was approximately 37% in Q1 2003 compared to 25% in Q1 2002, reflecting a smaller tax benefit from stock option exercises ($16,000 vs. $65,000).
- Cash Flow: Net cash from operating activities surged to $1.914 million from $648,000, aided by a $313,000 decrease in accounts receivable and reimbursement of progress payments.
Guidance, Outlook, and Risks
Management Commentary: Management attributes the increase in net income primarily to higher utilization of mature Gamma Knife units. The Company declared an annual dividend of $0.12 per share, payable April 4, 2003.
Liquidity and Capital Resources: The Company holds $11.34 million in cash and cash equivalents. Management believes cash flow from operations and existing resources are adequate to meet scheduled debt obligations of approximately $8.2 million due in the next 12 months.
Risks and Contingencies:
- Forward-looking statements involve risks related to the Gamma Knife business and the development of IMRT and "The Operating Room for the 21st Century" programs.
- Revenue concentration: 12 customers are on fee-per-use contracts, while 3 are on revenue-sharing agreements where the Company bears operating expenses.
- Legal Proceedings: None reported.
Investor Verification Checklist
- Debt Service Coverage: Verify the Company's ability to service $8.2 million in scheduled debt payments over the next 12 months given current cash flow trends.
- Unit Utilization: Confirm the 9% increase in procedures at mature units and the performance of the three new units added in the quarter.
- Contract Mix: Assess the financial impact of the 3 revenue-sharing ("retail") units versus the 12 fee-per-use units, particularly regarding operating expense responsibility.
- Dividend Sustainability: Review the impact of the $454,000 dividend payment on retained earnings and future liquidity.
- Write-off Impact: Understand the implications of the $58,000 write-off regarding the Brazil unit reallocation and future expansion costs.